초록 ▼

An apparatus is disclosed comprising an intake, configured to receive an emission from a pharmaceutical, a sensor, coupled to the intake, configured for detecting one or more constituents in the emission, a processor, configured for, collecting data from the sensor regarding the one or more constitu

An apparatus is disclosed comprising an intake, configured to receive an emission from a pharmaceutical, a sensor, coupled to the intake, configured for detecting one or more constituents in the emission, a processor, configured for, collecting data from the sensor regarding the one or more constituents, and analyzing the data to determine an analysis result, and a display device, coupled to the vaporizer component, configured for displaying the analysis result.

대표청구항 ▼

1. A pharmaceutical analysis device comprising: a device processor operable for controlling the pharmaceutical analysis device;at least one intake configured to receive at least a portion of at least one emission generated from a pharmaceutical composition;at least one sensing component operatively

1. A pharmaceutical analysis device comprising: a device processor operable for controlling the pharmaceutical analysis device;at least one intake configured to receive at least a portion of at least one emission generated from a pharmaceutical composition;at least one sensing component operatively coupled to the device processor and controlled in part by the device processor, wherein the at least one sensing component is configured to be in contact with at least a portion of the at least one emission generated from the pharmaceutical composition, wherein the at least one sensing component is operable to detect a plurality of constituent data associated with at least one constituent present in the at least one emission generated from the pharmaceutical composition;a memory operatively coupled to the device processor, wherein the memory is operable to store a plurality of standard pharmaceutical composition parameters, wherein the standard pharmaceutical composition parameters include at least one of a presence of at least one specified constituent in the pharmaceutical composition, a specified amount of at least one constituent in the pharmaceutical composition, an absence of at least one constituent in the pharmaceutical composition, a specified ratio between a plurality of specified constituents in the pharmaceutical composition, and combinations thereof; andat least one power source operatively coupled to the device processor and operable to generate a supply of power for the operation of the pharmaceutical analysis device;wherein the device processor is further operable to, receive at least a portion of the plurality of detected constituent data from the at least one sensing component,compare at least a portion of the plurality of detected constituent data for the at least one emission generated by the pharmaceutical composition to at least a portion of the plurality of standard pharmaceutical composition parameters and generate a plurality of comparison data therefrom,determine, based on at least a portion of the plurality of comparison data, whether the pharmaceutical composition is in accordance with at least one of the plurality of standard pharmaceutical composition parameters, anddetermine, based on at least a portion of at least one of the plurality of comparison data and the plurality of detected constituent data, the purity of the pharmaceutical composition. 2. The pharmaceutical analysis device of claim 1, wherein the device processor is further operable to determine, based on at least a portion of the plurality of detected constituent data, at least one emission quality, and generate a plurality of emission quality data therefrom. 3. The pharmaceutical analysis device of claim 2, wherein the at least one emission generated from the pharmaceutical composition comprises at least one of a vapor, a smoke, a gas, a fluid, and combinations thereof. 4. The pharmaceutical analysis device of claim 2, further comprising a sample chamber configured to receive the pharmaceutical composition therein, wherein the sample chamber is operable to subject the pharmaceutical composition to at least one test condition for a predetermined period of time so as to generate at least one emission therefrom, wherein the sample chamber is in fluid communication with the at least one intake for providing the at least one generated emission thereto. 5. The pharmaceutical analysis device of claim 4, wherein the at least one test condition to which the pharmaceutical composition is subjected comprises at least one of vaporizing at least a portion of the pharmaceutical composition, increasing the temperature of the pharmaceutical composition, decreasing the temperature of the pharmaceutical composition, changing a chemical composition of the pharmaceutical composition, altering a mechanical property of the pharmaceutical composition, and combinations thereof. 6. The pharmaceutical analysis device of claim 2, wherein the at least one sensing component is selected from the group of sensing components consisting of: a biochemical/chemical sensor, a genetic sensor, a thermal sensor, a radiation sensor, a mechanical sensor, an optical sensor, a magnetic sensor, an electrical sensor, and combinations thereof. 7. The pharmaceutical analysis device of claim 6, wherein the at least one sensing component is operable to detect at least one of an identification of a constituent in the at least one emission, an amount of a constituent in the at least one emission, a temperature of the at least one emission, a color of the at least one emission, a concentration of the at least one emission, an emission pH, an emission density, a particle size of a constituent in the at least one emission, a toxicity level of the at least one emission, and combinations thereof. 8. The pharmaceutical analysis device of claim 2, wherein the device processor is further operable to determine, based on at least a portion of at least one of the plurality of comparison data and the plurality of detected constituent data, whether the pharmaceutical composition comprises an impurity. 9. The pharmaceutical analysis device of claim 2, further comprising a display operatively coupled to the device processor, wherein the display is operable to display at least a portion of at least one of the plurality of comparison data and the plurality of emission quality data. 10. The pharmaceutical analysis device of claim 2, further comprising an input/output device operatively coupled to the device processor and controlled in part by the device processor, wherein the input/output device is operable to transmit at least a portion of at least one of the plurality of comparison data and the plurality of emission quality data to a remote device for processing thereof. 11. A method for analyzing at least one emission generated from a pharmaceutical composition by a pharmaceutical analysis device, wherein the pharmaceutical analysis device comprises (a) a device processor operable for controlling the pharmaceutical analysis device, (b) at least one intake configured to receive emissions generated from the pharmaceutical composition, (c) at least one sensing component operable to detect a plurality of constituent data associated with at least one constituent present in emissions generated from the pharmaceutical composition, and (d) a memory operable to store a plurality of standard pharmaceutical composition parameters, wherein the standard pharmaceutical composition parameters include at least one of a presence of at least one specified constituent in the pharmaceutical composition, a specified amount of at least one constituent in the pharmaceutical composition, an absence of at least one constituent in the pharmaceutical composition, a specified ratio between a plurality of specified constituents in the pharmaceutical composition, and combinations thereof, the method comprising: receiving, via the at least one air intake, at least one emission generated from the pharmaceutical composition;detecting, by the at least one sensing component, a plurality of constituent data associated with at least one constituent present in the at least one emission generated from the pharmaceutical composition;comparing, by the device processor, at least a portion of the plurality of detected constituent data for the at least one emission generated by the pharmaceutical composition to at least a portion of the plurality of standard pharmaceutical composition parameters and generating a plurality of comparison data therefrom;determining, by the device processor, based on at least a portion of the plurality of comparison data, whether the pharmaceutical composition is in accordance with at least one of the plurality of standard pharmaceutical composition parameter; anddetermining, by the device processor, based on at least a portion of at least one of the plurality of comparison data and the plurality of detected constituent data, the purity of the pharmaceutical composition. 12. The method of claim 11, further comprising: determining, by the device processor, at least one emission quality based on at least a portion of the plurality of detected constituent data;generating, by the device processor, a plurality of emission quality data therefrom; anddisplaying, via an associated display, at least a portion of at least one of the plurality of comparison data and the plurality of emission quality data. 13. The method of claim 12, further comprising transmitting, via an associated input/output device, at least a portion of at least one of the plurality of comparison data and the plurality of emission quality data to a remote device for processing thereof. 14. The method of claim 11, wherein the at least one emission generated from the pharmaceutical composition comprises at least one of a vapor, a smoke, a gas, a fluid, and combinations thereof. 15. The method of claim 11, further comprising subjecting the pharmaceutical composition to at least one test condition for a predetermined period of time so as to generate at least one emission therefrom and providing the at least one emission to the at least one intake. 16. The method of claim 15, wherein the at least one test condition to which the pharmaceutical composition is subjected comprises at least one of vaporizing at least a portion of the pharmaceutical composition, increasing the temperature of the pharmaceutical composition, decreasing the temperature of the pharmaceutical composition, changing a chemical composition of the pharmaceutical composition, altering a mechanical property of the pharmaceutical composition, and combinations thereof. 17. The method of claim 11, wherein the detecting a plurality of constituent data comprises detecting at least one of an identification of a constituent in the at least one emission, an amount of a constituent in the at least one emission, a temperature of the at least one emission, a color of the at least one emission, a concentration of the at least one emission, an emission pH, an emission density, a particle size of a constituent in the at least one emission, a toxicity level of the at least one emission, and combinations thereof. 18. The method of claim 11, further comprising determining, by the device processor, based on at least a portion of at least one of the plurality of comparison data and the plurality of detected constituent data, whether the pharmaceutical composition comprises an impurity.